Another study performed by Zhou et al. evaluated the efficacy of a mature-DC vaccine, which was transfected with adenoviral vector DNA containing a gene encoding the HCC tumor marker aspartate-β-hydroxylase (AAH), in treating HCC [55]. Here, ASPH is linked to hepatocellular carcinoma.